摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(2-(piperidin-1-yl)ethylamino)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine | 1358939-83-9

中文名称
——
中文别名
——
英文名称
5-(2-(piperidin-1-yl)ethylamino)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine
英文别名
8-chloro-N-(2-piperidin-1-ylethyl)-6H-pyrido[2,3-b][1,5]benzoxazepin-5-imine
5-(2-(piperidin-1-yl)ethylamino)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine化学式
CAS
1358939-83-9
化学式
C19H21ClN4O
mdl
——
分子量
356.855
InChiKey
JQWKOVNMSGDRRQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    49.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    New Pyridobenzoxazepine Derivatives Derived from 5-(4-Methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): Chemical Synthesis and Pharmacological Evaluation
    摘要:
    A series of new pyridobenzoxazepine derivatives with various heterocyclic amine side chains were synthesized to explore two main parameters related to the distal basic nitrogen. These compounds were tested for their affinity for dopamine D-2L and D-4, serotonin 5-HT1A and 5-HT2A, and adrenergic alpha(2A) receptors in comparison with 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,34][1,5]benzoxazepine, JL13 (1), and other diarylazepine derivatives. In terms of multireceptor target strategy, 2 and 5 present the most promising in vitro binding profile. Bulky, polar, and more flexible side chains are not favorable in this context. Compounds 2 and 5 were tested in adult rats to evaluate their long-term effects on dopamine and serotonin receptors density in different brain areas. Similar to 1 and other second-generation antipsychotic drugs, repeated treatment with 2 significantly increased D-1 and D-4 receptors in nucleus accumbens and caudate putamen and D-2 receptors in medial prefrontal cortex and hippocampus, while 5 significantly increased D-2 and D-4 receptors in nucleus accumbens. In addition, 2 increased 5-HT1A and decreased 5-HT2A receptors in cerebral cortex. In contrast, 5 did not alter levels of any 5-HT receptor subtype in any brain region examined. These results encourage further development of 2 as a novel second-generation antipsychotic agent.
    DOI:
    10.1021/jm2013419
点击查看最新优质反应信息

文献信息

  • New Pyridobenzoxazepine Derivatives Derived from 5-(4-Methylpiperazin-1-yl)-8-chloro-pyrido[2,3-<i>b</i>][1,5]benzoxazepine (JL13): Chemical Synthesis and Pharmacological Evaluation
    作者:Jean-François Liégeois、Marine Deville、Sébastien Dilly、Cédric Lamy、Floriane Mangin、Mélissa Résimont、Frank I. Tarazi
    DOI:10.1021/jm2013419
    日期:2012.2.23
    A series of new pyridobenzoxazepine derivatives with various heterocyclic amine side chains were synthesized to explore two main parameters related to the distal basic nitrogen. These compounds were tested for their affinity for dopamine D-2L and D-4, serotonin 5-HT1A and 5-HT2A, and adrenergic alpha(2A) receptors in comparison with 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,34][1,5]benzoxazepine, JL13 (1), and other diarylazepine derivatives. In terms of multireceptor target strategy, 2 and 5 present the most promising in vitro binding profile. Bulky, polar, and more flexible side chains are not favorable in this context. Compounds 2 and 5 were tested in adult rats to evaluate their long-term effects on dopamine and serotonin receptors density in different brain areas. Similar to 1 and other second-generation antipsychotic drugs, repeated treatment with 2 significantly increased D-1 and D-4 receptors in nucleus accumbens and caudate putamen and D-2 receptors in medial prefrontal cortex and hippocampus, while 5 significantly increased D-2 and D-4 receptors in nucleus accumbens. In addition, 2 increased 5-HT1A and decreased 5-HT2A receptors in cerebral cortex. In contrast, 5 did not alter levels of any 5-HT receptor subtype in any brain region examined. These results encourage further development of 2 as a novel second-generation antipsychotic agent.
查看更多